NCT01589523View on ClinicalTrials.gov

GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis

PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 22, 2019

Study Completion Date

January 22, 2019

Conditions
Bile Acid Synthesis DefectInborn Error of Bile Acid MetabolismInborn Error of Bile Acid Conjugation
Interventions
DRUG

Glycocholic Acid

10-15mg/kg body weight/day taken orally. Supplied as either liquid or 50mg capsules.

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01589523 - GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis | Biotech Hunter | Biotech Hunter